J&J’s DePuy Synthes launches Velys surgical robot for spine
Johnson & Johnson’s (NYSE: JNJ)+
DePuy Synthes announced today that it launched a dual-use robotics and standalone navigation platform that uses its Velys robot in spine surgery.
Johnson & Johnson’s (NYSE: JNJ)+
DePuy Synthes announced today that it launched a dual-use robotics and standalone navigation platform that uses its Velys robot in spine surgery.
Inspire Medical Systems (NYSE: INSP)+ announced today that it received FDA approval for its Inspire V therapy system.